Literature DB >> 33855668

Evaluating the multivisceral involvement on adult-onset Still's disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study.

Ilenia Di Cola1, Federico Bruno1, Onorina Berardicurti1, Riccardo Monti1, Alessandro Conforti1, Alessandra Di Sibio1, Viktoriya Pavlych1, Carlo Masciocchi1, Antonio Barile1, Paola Cipriani1, Piero Ruscitti2.   

Abstract

In this study, we aimed at describing the multivisceral involvement on adult-onset Still's disease (AOSD) to retrieve imaging-based differences in patients with and without macrophage activation syndrome (MAS). From our historical cohort, patients were assessed among those who underwent a total body CT scan. Clinical and CT scan characteristics of AOSD patients with and without MAS were compared. Out of 39 AOSD patients evaluated, 14 were complicated by MAS. These patients showed higher values of ferritin and systemic score. AOSD patients with MAS presented a higher prevalence of lung disease, hepatomegaly, splenomegaly, abdominal effusions, and lymph node enlargement than others without this complication. In addition, the presence of these manifestations significantly correlated with the systemic score, furtherly reinforcing its prognostic value. Due to the specific design of our study, our findings could be burdened by a selection bias since assessing those patients underwent a total body CT scan. Thus, these data should be prudently generalised suggesting the need of further studies to fully elucidate this issue. Our findings showed a higher prevalence of multiorgan involvement in AOSD patients with MAS, suggesting imaging-based differences, although other studies are needed to fully assess this issue. Pulmonary disease, hepatomegaly, splenomegaly, lymph node enlargement, and abdominal effusions were associated with a more aggressive subset of AOSD. Key Points •The importance of an accurate assessment AOSD multivisceral involvement is suggested since it is associated with life-threatening complications. •A higher prevalence of multiorgan involvement in AOSD patients with MAS could be recognised, than others without this complication, suggesting imaging-based differences. •AOSD multivisceral involvement may correlate with the systemic score, furtherly reinforcing its prognostic value.

Entities:  

Keywords:  Adult-onset Still’s disease; Imaging; Macrophage activation syndrome; Mortality

Year:  2021        PMID: 33855668     DOI: 10.1007/s10067-021-05727-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

1.  Preliminary criteria for classification of adult Still's disease.

Authors:  M Yamaguchi; A Ohta; T Tsunematsu; R Kasukawa; Y Mizushima; H Kashiwagi; S Kashiwazaki; K Tanimoto; Y Matsumoto; T Ota
Journal:  J Rheumatol       Date:  1992-03       Impact factor: 4.666

Review 2.  Adult-onset Still's disease.

Authors:  Mathieu Gerfaud-Valentin; Yvan Jamilloux; Jean Iwaz; Pascal Sève
Journal:  Autoimmun Rev       Date:  2014-03-19       Impact factor: 9.754

3.  Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort.

Authors:  Piero Ruscitti; Daniela Iacono; Francesco Ciccia; Giacomo Emmi; Paola Cipriani; Rosa Daniela Grembiale; Federico Perosa; Lorenzo Emmi; Giovanni Triolo; Roberto Giacomelli; Gabriele Valentini
Journal:  J Rheumatol       Date:  2018-04-15       Impact factor: 4.666

4.  Adult-onset Still's disease-associated interstitial lung disease represents severe phenotype of the disease with higher rate of haemophagocytic syndrome and relapse.

Authors:  Yukiko Takakuwa; Hironari Hanaoka; Tomofumi Kiyokawa; Harunobu Iida; Kana Ishimori; Toshimasa Uekusa; Hidehiro Yamada; Kimito Kawahata
Journal:  Clin Exp Rheumatol       Date:  2019-02-11       Impact factor: 4.473

5.  Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.

Authors:  Piero Ruscitti; Paola Cipriani; Vasiliki Liakouli; Daniela Iacono; Ilenia Pantano; Francesco Caso; Federico Perosa; Fabiola Atzeni; Francesco Paolo Cantatore; Raffaele Scarpa; Francesco Ciccia; Roberto Giacomelli
Journal:  Rheumatol Int       Date:  2019-07-01       Impact factor: 2.631

Review 6.  A comprehensive review on adult onset Still's disease.

Authors:  Roberto Giacomelli; Piero Ruscitti; Yehuda Shoenfeld
Journal:  J Autoimmun       Date:  2018-08-01       Impact factor: 7.094

Review 7.  Adult haemophagocytic syndrome.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Armando López-Guillermo; Munther A Khamashta; Xavier Bosch
Journal:  Lancet       Date:  2013-11-27       Impact factor: 79.321

8.  Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers.

Authors:  Piero Ruscitti; Paola Cipriani; Francesco Masedu; Daniela Iacono; Francesco Ciccia; Vasiliki Liakouli; Giuliana Guggino; Francesco Carubbi; Onorina Berardicurti; Paola Di Benedetto; Marco Valenti; Giovanni Triolo; Gabriele Valentini; Roberto Giacomelli
Journal:  BMC Med       Date:  2016-12-01       Impact factor: 8.775

Review 9.  Mechanisms, biomarkers and targets for adult-onset Still's disease.

Authors:  Eugen Feist; Stéphane Mitrovic; Bruno Fautrel
Journal:  Nat Rev Rheumatol       Date:  2018-10       Impact factor: 20.543

Review 10.  Life-threatening complications of adult-onset Still's disease.

Authors:  Petros Efthimiou; Sabeeda Kadavath; Bella Mehta
Journal:  Clin Rheumatol       Date:  2014-01-17       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.